Iron overload and HFE gene mutations in Czech patients with chronic liver diseases

Disease Markers

Volumn 32, Issue 1, 2012, Pages 65-72

  Dostalikova Cimburova, Marketa ^a   Kratka, Karolina ^a   Stransky, Jaroslav ^a   Putova, Ivana ^a,b   Cieslarova, Blanka ^a   Horak, Jiri ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

alcoholic liver disease; chronic hepatitis; hemochromatosis; HFE gene

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CZECH REPUBLIC; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HFE GENE; HOMOZYGOSITY; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSFERRIN BLOOD LEVEL;

HEPATITIS C VIRUS;

EID: 84856686389     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2012-0861     Document Type: Article

References (46)

1. H.L. Bonkovsky, R.W. Lambrecht and Y. Shan, Iron as a co-morbid factor in nonhemochromatotic liver disease, Alcohol 30 (2003), 137-144. (Pubitemid 37040860)
2. G. Sebastiani and A.P. Walker, HFE gene in primary and secondary hepatic iron overload, World J Gastroenterol 13 (2007), 4673-4689. (Pubitemid 47455558)
3. J.N. Feder, A. Gnirke, W. Thomas et al., A novel MHC class I-like gene is mutated in patients with hereditary haemochro-matosis, Nat Genet 13 (1996), 399-408. (Pubitemid 26256612)
4. D. Gleeson, S. Evans, M. Bradley et al., HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls, Am J Gastroenterol 101 (2006), 304-310. (Pubitemid 43381672)
5. D.D. Harrison-Findik, Role of alcohol in the regulation of iron metabolism, World J Gastroenterol 13 (2007), 4925-4930. (Pubitemid 47496823)
6. A.L. Martinelli, A.B. Filho, R.F. Franco et al., Liver iron deposits in hepatitis B patients: association with severity of liver disease but not with hemochromatosis gene mutations, J Gastroenterol Hepatol 19 (2004), 1036-1041. (Pubitemid 39237439)
7. D.F. Wallace and V.N. Subramaniam, Co-factors in liver disease: the role of HFE-related hereditary hemochromatosis and iron, Biochim Biophys Acta 1790 (2009), 663-670.
8. M.V. Machado, P. Ravasco, A. Martins et al., Iron homeosta-sis and H63D mutations in alcoholics with and without liver disease, World J Gastroenterol 15 (2009), 106-111.
9. Y.H. Mah, J.H. Kao, C.J. Liu et al., Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan, Liver Int 25 (2005), 214-219.
10. C.A. Aoki, L. Rossaro, R. Ramsamooj et al., Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C, J Clin Gastroenterol 39 (2005), 71-74. (Pubitemid 40041349)
11. K. Bridle, T.K. Cheung, T. Murphy et al., Hepcidin is down-regulated in alcoholic liver injury: implications for the patho-genesis of alcoholic liver disease, Alcohol Clin Exp Res 30 (2006), 106-112. (Pubitemid 43341402)
12. N. Fujita, R. Sugimoto, M. Takeo et al., Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C, Mol Med 13 (2007), 97-104. (Pubitemid 46786838)
13. D. Girelli, M. Pasino, J.B. Goodnough et al., Reduced serum hepcidin levels in patients with chronic hepatitis C, J Hepatol 51 (2009), 845-852.
14. D.D. Harrison-Findik, D. Schafer, E. Klein et al., Alcohol metabolism-mediated oxidative stress down-regulates hep-cidin transcription and leads to increased duodenal iron transporter expression, J Biol Chem 281 (2006), 22974-22982.
15. D.D. Harrison-Findik, Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease? World J Gastroenterol 15 (2009), 1186-1193.
16. L. Pacal, P. Husa, V. Znojil and K. Kankova, HFE C282Y gene variant is a risk factor for the progression to decompensated liver disease in chronic viral hepatitis C subjects in the Czech population, Hepatol Res 37 (2007), 740-747. (Pubitemid 47054780)
17. T. Pucelikova, B. Cieslarova, I. Putova, et al., Prevalence of HFE gene C282Y and H63D mutations and elevated iron biochemistries in patients with non-alcoholic fatty liver and alcoholic liver disease, Ces a slov Gastroent a Hepatol 58 (2004), 89-93. (Pubitemid 38798722)
18. I. Putova, M. Cimburova, B. Cieslarova et al., HFE genotype in patients with hemochromatosis and other liver diseases with iron overload in the Czech republic, Ces a slov Gastroent a Hepatol 56 (2002), 214-219. (Pubitemid 36125537)
19. M. Cimburova, I. Putova, H. Provaznikova et al., S65C and other mutations in the haemochromatosis gene in the Czech population, Folia Biol (Praha) 51 (2005), 172-176. (Pubitemid 43056596)
20. C. Ellervik, H. Birgens, A. Tybjaerg-Hansen and B.G. Nordestgaard, Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls, Hepatology 46 (2007), 1071-1080. (Pubitemid 350144771)
21. K. Kratka, M. Dostalikova-Cimburova, H. Michalikova et al., High prevalence of HFE gene mutations in patients with por-phyria cutanea tarda in the Czech Republic, Br J Dermatol 159 (2008), 585-590.
22. T. Ghaziani, S.M. Alavian, M.R. Zali et al., Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection, Hepatol Res 37 (2007), 172-178. (Pubitemid 46403813)
23. A. Piperno, A. Vergani, I. Malosio et al., Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations, Hepatology 28 (1998), 1105-1109. (Pubitemid 28450273)
24. P.A. Gochee, L.W. Powell, D.J. Cullen et al., A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation, Gastroenterology 122 (2002), 646-651. (Pubitemid 34173816)
25. A.F. Remacha, M.P. Sarda, M.J. Barcelo et al., Genotype-phenotype correlation in a Spanish population homozygous for the H63D mutation of the HFE gene, Ann Hematol 85 (2006), 340-342. (Pubitemid 43732661)
26. J. Samarasena, W. Winsor, R. Lush et al., Individuals homozy-gous for the H63D mutation have significantly elevated iron indexes,Dig Dis Sci 51 (2006), 803-807.
27. H.L. Bonkovsky, N. Troy, K. McNeal et al., Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C, J Hepatol 37 (2002), 848-854. (Pubitemid 35404226)
28. L. Kazemi-Shirazi, C. Datz, T. Maier-Dobersberger et al., The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C, Gastroenterology 116 (1999), 127-134. (Pubitemid 29013501)
29. B.C. Smith, J. Gorve, M.A. Guzail et al., Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C, Hepatology 27 (1998), 1695-1699. (Pubitemid 28264696)
30. A. Erhardt, A. Maschner-Olberg, C. Mellenthin et al., HFE mutations and chronic hepatitis C: H63D and C282Y het-erozygosity are independent risk factors for liver fibrosis and cirrhosis, J Hepatol 38 (2003), 335-342. (Pubitemid 36286547)
31. S.G. Gehrke, W. Stremmel, I. Mathes et al., Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype, J Mol Med 81 (2003), 780-787. (Pubitemid 38058160)
32. A. Geier, M. Reugels, R. Weiskirchen et al., Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C, Liver Int 24 (2004), 285-294. (Pubitemid 39162068)
33. L. Valenti, E.A. Pulixi, P. Arosio et al., Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis, Haematologica 92 (2007), 1037-1042. (Pubitemid 350144209)
34. S. Distante, K. Bjoro, K.B. Hellum et al., Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection, Liver 22 (2002), 269-275. (Pubitemid 34846366)
35. C. Hezode, C. Cazeneuve, O. Coue et al., Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions, J Hepatol 31 (1999), 979-984.
36. F. Negro, K. Samii, L. Rubbia-Brandt et al., Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis, J Med Virol 60 (2000), 21-27.
37. K. Sikorska, K.P. Bielawski, P. Stalke et al., HFE gene mutations in Polish patients with disturbances of iron metabolism: an initial assessment, Int J Mol Med 16 (2005), 1151-1156.
38. D. Thorburn, G. Curry, R. Spooner et al., The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C, Gut 50 (2002), 248-252. (Pubitemid 34087940)
39. J. Grove, A.K. Daly, A.D. Burt et al., Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease, Gut 43 (1998), 262-266. (Pubitemid 28348332)
40. E. Lauret, M. Rodriguez, S. Gonzalez et al., HFE gene mutations in alcoholic and virus-related cirrhotic patients with hep-atocellular carcinoma, Am J Gastroenterol 97 (2002), 1016-1021. (Pubitemid 34408263)
41. G. Robinson, S. Narasimhan, M. Weatherall and R. Beasley, Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification, J Gastroenterol Hepatol 22 (2007), 852-854. (Pubitemid 46911016)
42. C.N. Starcevic, S. Stepec, S. Ristic et al., Hemochromatosis gene mutations in patients with alcoholic cirrhosis, Clin Genet 70 (2006), 257-259. (Pubitemid 44225915)
43. E. Beutler, V. Felitti, T. Gelbart and N. Ho, Genetics of iron storage and hemochromatosis, Drug Metab Dispos 29 (2001), 495-499. (Pubitemid 32275523)
44. A.T. Merryweather-Clarke, J.J. Pointon, A.M. Jouanolle et al., Geography of HFE C282Y and H63D mutations, Genet Test 4 (2000), 183-198. (Pubitemid 30618706)
45. R. Mifuji, Y. Kobayashi, N. Ma et al., Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C, J Gastroenterol Hepatol 21 (2006), 144-151.
46. M. Takeo, Y. Kobayashi, N. Fujita et al., Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C, J Gastroenterol Hepatol 20 (2005), 562-569. (Pubitemid 40755268)